‘Pushing food around the plate’: How weight-loss drugs are changing what Australia eats
详细摘要
The first GLP-1 weight-loss tablets arrive in Australia as chefs, supermarkets and fast-food chains rethink portion sizes and menus.
You've used all of your gift articles. 3 more will become available on the 1st of every month.
Celebrated restaurateur and cookbook author Karen Martini has seen all sorts of trends during her career. The latest, the explosive growth in use of GLP-1 weight-loss drugs, leaves her perplexed.
“What I find most disappointing is groups of well-dressed, thinner men and women out to lunch or dinner, who still want the experience of going out, eating and drinking,” Martini says. “And all they do is push the food around the plates pretending to eat, usually ordering too much to compensate for not eating. I’ve seen this from time to time in restaurants in Melbourne, Sydney and Europe.”
It’s a sad state of affairs for all chefs making beautiful food, she says. “Every chef wants to please the diner and see flavours savoured, and clean plates sent back to the kitchen. We thrive on people enjoying food, rather than pushing it aside and not being able to finish.”
Australians are obsessed with health and longevity, but have an excess weight problem: official figures show 14.6 million of us are overweight or obese (67 per cent of adults and 27 per cent of children).
These excess-weight figures are tipped to tumble, however, as GLP-1 medicines become cheaper and easier to use. This month, the medicine regulator approved two weight-loss pills, Eli Lilly’s daily pill, marketed as Foundayo, and Novo Nordisk Pharmaceuticals’ Wegovy pill, which are set to make weight-loss treatments more attractive for many than the weekly injections available on the market so far. Wegovy will be available for sale on Friday; Eli Lilly says Foundayo will be available “in coming days”.
“I suspect we may look back on their impact on society and say it’s been one of the most significant changes in a long time,” says Ben Willee of Spinach Advertising, whose firm has done campaigns for food companies.
The drugs have evolved from treating diabetes to managing obesity. They reduce their users’ appetite and weight.
“You…
文章开头,摘自The Sydney Morning Herald。如需阅读全文,请前往媒体网站。
MarketNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.smh.com.au)


